Showing 5591-5600 of 5643 results for "".
- Optimo Medical Receives CE Mark for Optimeyes Surgical Planning Toolhttps://modernod.com/news/optimo-medical-receives-ce-mark-for-optimeyes-surgical-planning-tool/2480233/Switzerland-based Optimo Medical AG announced that it has received CE Mark for Optimeyes as a Class 2b medical device. The Optimeyes software predicts in a patient-specific way the influence of physical interventions in the cornea, allowing it to simulate and evaluate treatment results in
- American Academy of Optometry 2018 San Antonio Education Program Announcedhttps://modernod.com/news/american-academy-of-optometry-2018-san-antonio-education-program-announced/2480235/The American Academy of Optometry is pleased to announce highlights of the education program taking place at Academy 2018 San Antonio, November 7-10, 2018. The annual meeting offers a wide array of clinically relevant CE courses and cutting-edge research in the clinical and vision sciences. Atten
- Alcon Adds New Gemstone Collection to Air Optix Colors Lens Portfolio and Introduces 2-Count Packshttps://modernod.com/news/alcon-adds-new-gemstone-collection-to-air-optix-colors-lens-portfolio-and-introduces-2-count-packs/2480236/Alcon has introduced its new Air Optix Colors Gemstone Collection of color contact lenses, with three new colors – Amethyst, True Sapphire, and Turquoise. Now offering a total of 12 colors, Air Optix Colors lenses appeal to a wide range of patients and offer a strong incremental revenue potential
- Shire Announces Sale of Oncology Business to Servier for $2.4 Billionhttps://modernod.com/news/shire-announces-sale-of-oncology-business-to-servier-for-2-4-billion/2480237/Shire announced that it has entered into a definitive agreement with privately held French pharmaceutical group Servier S.A.S. to sell its Oncology business for $2.4 billion. “This transaction is a key milestone for Shire, demonstrating the clear value embedded in our portfolio. While the
- Ivantis Announces Results of Comparative MIGS Clinical Trialhttps://modernod.com/news/ivantis-announces-results-of-comparative-migs-clinical-trial/2480238/Ivantis, developer of the Hydrus Microstent, announced the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS). Results from the study will be presented by David Chang, MD, clinical professor of Ophthalmology at the University of California, San Francisco, during
- Genetically Modified Cornea Safely and Effectively Prevents Rejection Post-Transplantationhttps://modernod.com/news/genetically-modified-cornea-safely-and-effectively-prevents-rejection-post-transplantation/2480247/Researchers engineered a donor cornea, introducing two genes intended to prevent new blood vessel formation following transplantation, and have shown this novel approach to be safe, well tolerated, and effective at reducing the risk of tissue rejection in a high-risk rabbit model, according to a
- Aerie Pharmaceuticals Announces Appointment of Scott Laranjo as Director, Marketing, Roclatanhttps://modernod.com/news/aerie-pharmaceuticals-announces-appointment-of-scott-laranjo-as-director-marketing-roclatan/2480254/Aerie Pharmaceuticals announced the appointment of Scott Laranjo as Director, Marketing, Roclatan, reporting to Deanne Melloy, Aerie’s Vice President of Marketing. Mr. Laranjo will direct future marketing activities associated with Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005
- Alcon Introduces Systane Complete Solution for Dry Eyehttps://modernod.com/news/alcon-introduces-systane-complete-solution-for-dry-eye/2480262/Alcon has introduced Systane Complete, a new formula designed to provide soothing relief for every major type of dry eye. The new product joins the Systane family of dry eye drops as a first-line treatment option for people who suffer from evaporative dry eye, aqueous tear deficient dry eye, or m
- SIFI Announces Approval of Mini Well Ready IOL in Singaporehttps://modernod.com/news/sifi-announces-approval-of-mini-well-ready-iol-in-singapore/2480263/Italian ophthalmic company SIFI has announced the approval of the Mini Well Ready IOL by Singapore’s Health Science’s Authority. Mini Well Ready is an innovative, aspherical, EDOF, progressive IOL designed for the surgical correction of presbyopia. “It is today increasingly rec
- Zepto Receives Award for Best Capsulotomy Technology 2017https://modernod.com/news/zepto-receives-award-for-best-capsulotomy-technology-2017/2480270/Mynosys Cellular Devices has announced that its flagship automated capsulotomy device, »Zepto, has been selected as the best capsulotomy technology by Cataract and Refrac